These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8818647)

  • 1. Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial.
    Leavitt MC; Yu M; Wong-Staal F; Looney DJ
    Gene Ther; 1996 Jul; 3(7):599-606. PubMed ID: 8818647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients.
    Macpherson JL; Boyd MP; Arndt AJ; Todd AV; Fanning GC; Ely JA; Elliott F; Knop A; Raponi M; Murray J; Gerlach W; Sun LQ; Penny R; Symonds GP; Carr A; Cooper DA
    J Gene Med; 2005 May; 7(5):552-64. PubMed ID: 15655805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial capillary culture: expansion and retroviral transduction of CD4+ T-lymphocytes for clinical application.
    Knop AE; Arndt AJ; Raponi M; Boyd MP; Ely JA; Symonds G
    Gene Ther; 1999 Mar; 6(3):373-84. PubMed ID: 10435087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro.
    Klebba C; Ottmann OG; Scherr M; Pape M; Engels JW; Grez M; Hoelzer D; Klein SA
    Gene Ther; 2000 Mar; 7(5):408-16. PubMed ID: 10694823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
    Ramezani A; Ding SF; Joshi S
    Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells.
    Kaneko H; Suzuki H; Abe T; Miyano-Kurosaki N; Takaku H
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1220-7. PubMed ID: 16979590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 replication by an anti-tat hammerhead ribozyme.
    Jackson WH; Moscoso H; Nechtman JF; Galileo DS; Garver FA; Lanclos KD
    Biochem Biophys Res Commun; 1998 Apr; 245(1):81-4. PubMed ID: 9535787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy.
    Hörster A; Teichmann B; Hormes R; Grimm D; Kleinschmidt J; Sczakiel G
    Gene Ther; 1999 Jul; 6(7):1231-8. PubMed ID: 10455431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells.
    Yamada O; Kraus G; Leavitt MC; Yu M; Wong-Staal F
    Virology; 1994 Nov; 205(1):121-6. PubMed ID: 7975207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitat gene therapy: a candidate for late-stage AIDS patients.
    Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
    Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV replication: a powerful antiviral strategy by IFN-beta gene delivery in CD4+ cells.
    Brule F; Khatissian E; Benani A; Bodeux A; Montagnier L; Piette J; Lauret E; Ravet E
    Biochem Pharmacol; 2007 Sep; 74(6):898-910. PubMed ID: 17662695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assay system to detect the selective advantage of anti-HIV ribozyme expressing CD4+ T-lymphocytes.
    Klein SA; Klebba C; Engels JW
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):629-34. PubMed ID: 11563080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS.
    Manca F; Fenoglio D; Franchin E; Saverino D; Li Pira G; Buffa F; Bignardi D; Del Pup L; Palù G
    Gene Ther; 1997 Nov; 4(11):1216-24. PubMed ID: 9425445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
    Wingard JB; Anderson B; Weissman D
    Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D; Notkins AL; Zhou P
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells.
    Yam P; Jensen M; Akkina R; Anderson J; Villacres MC; Wu J; Zaia JA; Yee JK
    Mol Ther; 2006 Aug; 14(2):236-44. PubMed ID: 16647299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.
    Wong-Staal F; Poeschla EM; Looney DJ
    Hum Gene Ther; 1998 Nov; 9(16):2407-25. PubMed ID: 9829540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
    Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
    Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.